SCHEMBL847565

SCHEMBL847565

Cc1cc2cc(-c3nc(N)nc(N)c3-c3ccc4[nH]c(C)cc4c3)ccc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.49
KEAP1 Q14145 1/20 0.49
PTGS2 P35354 1/20 0.40
AXL P30530 2/20 0.40
VCP P55072 3/20 0.38
EGFR P00533 2/20 0.36
KDR P35968 2/20 0.36
AURKA O14965 1/20 0.36
DYRK3 O43781 1/20 0.36
ROCK2 O75116 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
ABL1 P00519 1/20 0.36
INSR P06213 1/20 0.36
FYN P06241 1/20 0.36
CSF1R P07333 1/20 0.36
LYN P07948 1/20 0.36
KIT P10721 1/20 0.36
FGFR1 P11362 1/20 0.36
FLT1 P17948 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12612669 0.87 CYP2A6 (0.50) CYP2A6KEAP1PTGS2AXLVCP
SCHEMBL27939440 0.79 CYP2A6 (0.42) CYP2A6KEAP1PTGS2AXLVCP
SCHEMBL846923 0.77 BRD4 (0.47) EGFRKDRABL1
SCHEMBL12520537 0.76 HRH4 (0.49) ROCK2ROCK1
SCHEMBL12520432 0.74 DHFR (0.56) CYP2A6KEAP1PTGS2AXLVCP
SCHEMBL10122036 0.72 CYP2A6 (0.72) CYP2A6KEAP1PTGS2AXLVCP
SCHEMBL18000222 0.67 MMP2 (0.56) CYP2A6KEAP1PTGS2AXLMAP4K4
SCHEMBL397246 0.67 CYP2A6 (1.00) CYP2A6KEAP1PTGS2AXLVCP
SCHEMBL5797966 0.66 PTGS2 (0.60) CYP2A6KEAP1PTGS2AXLEGFR
SCHEMBL2598585 0.66 CYP2A6 (0.45) CYP2A6KEAP1VCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433636-A1 Treatment of Malignant Diseases Medizinische Universität Wien (AT) 2012-03-28 EP claimed
EP-2433636-A1 Treatment of Malignant Diseases Medizinische Universität Wien (AT) 2012-03-28 EP disclosed
EP-2433636-A1 Treatment of Malignant Diseases Medizinische Universität Wien (AT) 2012-03-28 EP disclosed